These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 27590006)

  • 1. MMP-14 and CD44 in Epithelial-to-Mesenchymal Transition (EMT) in ovarian cancer.
    Vos MC; Hollemans E; Ezendam N; Feijen H; Boll D; Pijlman B; van der Putten H; Klinkhamer P; van Kuppevelt TH; van der Wurff AA; Massuger LF
    J Ovarian Res; 2016 Sep; 9(1):53. PubMed ID: 27590006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging prognostic markers related to mesenchymal characteristics of poorly differentiated breast cancers.
    Scimeca M; Antonacci C; Colombo D; Bonfiglio R; Buonomo OC; Bonanno E
    Tumour Biol; 2016 Apr; 37(4):5427-35. PubMed ID: 26563370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD44 enhances the epithelial-mesenchymal transition in association with colon cancer invasion.
    Cho SH; Park YS; Kim HJ; Kim CH; Lim SW; Huh JW; Lee JH; Kim HR
    Int J Oncol; 2012 Jul; 41(1):211-8. PubMed ID: 22552741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteration of epithelial-mesenchymal transition markers in human normal ovaries and neoplastic ovarian cancers.
    Yi BR; Kim TH; Kim YS; Choi KC
    Int J Oncol; 2015 Jan; 46(1):272-80. PubMed ID: 25310727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD44 regulates pancreatic cancer invasion through MT1-MMP.
    Jiang W; Zhang Y; Kane KT; Collins MA; Simeone DM; di Magliano MP; Nguyen KT
    Mol Cancer Res; 2015 Jan; 13(1):9-15. PubMed ID: 25566991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelial to mesenchymal transition might be induced via CD44 isoform switching in colorectal cancer.
    Mashita N; Yamada S; Nakayama G; Tanaka C; Iwata N; Kanda M; Kobayashi D; Fujii T; Sugimoto H; Koike M; Nomoto S; Fujiwara M; Kodera Y
    J Surg Oncol; 2014 Nov; 110(6):745-51. PubMed ID: 24975268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial-mesenchymal transition in patients of pulmonary adenocarcinoma: correlation with cancer stem cell markers and prognosis.
    Sung WJ; Park KS; Kwak SG; Hyun DS; Jang JS; Park KK
    Int J Clin Exp Pathol; 2015; 8(8):8997-9009. PubMed ID: 26464642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of epithelial-mesenchymal transition and cancer stem cell-like phenotypes has independent prognostic value in gastric cancer.
    Ryu HS; Park DJ; Kim HH; Kim WH; Lee HS
    Hum Pathol; 2012 Apr; 43(4):520-8. PubMed ID: 22018628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD44v6 expression is related to mesenchymal phenotype and poor prognosis in patients with colorectal cancer.
    Saito S; Okabe H; Watanabe M; Ishimoto T; Iwatsuki M; Baba Y; Tanaka Y; Kurashige J; Miyamoto Y; Baba H
    Oncol Rep; 2013 Apr; 29(4):1570-8. PubMed ID: 23404221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelial mesenchymal transition correlates with CD24+CD44+ and CD133+ cells in pancreatic cancer.
    Zhang Y; Wei J; Wang H; Xue X; An Y; Tang D; Yuan Z; Wang F; Wu J; Zhang J; Miao Y
    Oncol Rep; 2012 May; 27(5):1599-605. PubMed ID: 22322379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epithelial-Mesenchymal Transition Predicts Survival in Oral Squamous Cell Carcinoma.
    Wangmo C; Charoen N; Jantharapattana K; Dechaphunkul A; Thongsuksai P
    Pathol Oncol Res; 2020 Jul; 26(3):1511-1518. PubMed ID: 31471883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphological and immunohistochemical identification of epithelial-to-mesenchymal transition in clinical prostate cancer.
    Kolijn K; Verhoef EI; van Leenders GJ
    Oncotarget; 2015 Sep; 6(27):24488-98. PubMed ID: 26041890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of epithelial-mesenchymal transition-related markers in triple-negative breast cancer: ZEB1 as a potential biomarker for poor clinical outcome.
    Jang MH; Kim HJ; Kim EJ; Chung YR; Park SY
    Hum Pathol; 2015 Sep; 46(9):1267-74. PubMed ID: 26170011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD24 and S100A4 expression in resectable pancreatic cancers with earlier disease recurrence and poor survival.
    Lee SH; Kim H; Hwang JH; Shin E; Lee HS; Hwang DW; Cho JY; Yoon YS; Han HS; Cha BH
    Pancreas; 2014 Apr; 43(3):380-8. PubMed ID: 24622067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Epithelial-Mesenchymal Transition, E-cadherin and Tumor Progression in Ovarian Serous Tumors.
    Bozhkova DM; Poryazova-Markova EG
    Folia Med (Plovdiv); 2019 Jun; 61(2):296-302. PubMed ID: 31301662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The stromal tumor-infiltrating lymphocytes, cancer stemness, epithelial-mesenchymal transition, and B7-H4 expression in ovarian serous carcinoma.
    Hwang C; Lee HJ; Na JY; Kim KH; Song YJ; Kim JY; Kim K; Shin DH; Park JY; Kim SY; Lee JH; Choi KU
    J Ovarian Res; 2023 Jan; 16(1):3. PubMed ID: 36609273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of adhesion molecules expression for estimation of serous ovarian cancer prognosis.
    Ryabtseva OD; Lukianova NY; Shmurakov YA; Polishchuk LZ; Antipova SV
    Exp Oncol; 2013 Sep; 35(3):211-8. PubMed ID: 24084461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinase-14 induces epithelial-to-mesenchymal transition in synovial sarcoma.
    Liu M; Qi Y; Zhao L; Chen D; Zhou Y; Zhou H; Lv Y; Zhang L; Jin S; Li S; Zou H; Jia W; Wang C; Jiang J; Liang W; Pang L; Li F
    Hum Pathol; 2018 Oct; 80():201-209. PubMed ID: 29935194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E-cadherin÷CD44 immunophenotype in the epithelial-mesenchymal transition of bladder urothelial carcinomas.
    Stepan AE; Pirici D; Bălăşoiu M; Novac MB; Drocaş AI; Ciurea RN; Stepan D; Gheonea DI; Simionescu CE
    Rom J Morphol Embryol; 2015; 56(1):85-91. PubMed ID: 25826491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multivariate analysis of adhesion molecules expression in assessment of colorectal cancer.
    Ngan CY; Yamamoto H; Seshimo I; Ezumi K; Terayama M; Hemmi H; Takemasa I; Ikeda M; Sekimoto M; Monden M
    J Surg Oncol; 2007 Jun; 95(8):652-62. PubMed ID: 17443723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.